Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.


Project Scope 

Impact assessment of the estimands framework and recommendations/best practices (where applicable) for implementing the framework in the following areas:

  • Data Collect Design/CDASH
  • SDTM
  • ADaM (including handling of intercurrent events, missing data imputation) – Analysis Displays
  • cSDRG and ADRG

Development of new standards is not in scope, and any impact findings that may necessitate new standard development will be shared with CDISC for their consideration. Examples may be created on how to implement the framework by using permitted extensions to the existing data standards.



Project LeadsEmail
Chris Price (Roche) 

chris.price.cp1@roche.com

Lori VanMeter (Janssen Research & Development)lvanmet@ITS.JNJ.com
Katie Warren (PHUSE Project Assistant)

katie@phuse.global


Objectives & DeliverablesTimelines

Review current company practices 

Q1 2022

Develop conference abstract 

Q2 2022

Draft paper

Q3 2022 

Conference slides 

Q4 2022

Final White Paper ready for Public Review

Q4 2022

Publish White Paper 

Submit abstracts for multiple conferences 

Q2 2023

Develop draft White Paper for internal project review prior to PHUSE Working Group Review and Public Review

Q3
Q1
2023


Status
colourBlue
titleCURRENT STATUS
Q3/4 2022 Q1 2023

Working on a White Paper

  • Meeting on a regular basis to gather information for the White Paper
  • Sub-teams have been formed 
  • Initiate drafting of white paper based on finalisation of discussions in both collection and analysis sub-teams  
  • Review of proposals by CDISC 


    Project MembersOrganisation 
    Ashik Chowdhury Cytel 
    Alexandra CochinaireJohnson & Johnson
    Arman SabbaghiPurdue University
    Armin SchuelerMerckgroup 
    Banoo Madhanagopal Bayer 

    Benoît Sansas

    Pierre Fabre
    Bess LeroyCDISC
    Brent Burger Jazz Pharma
    Cedric Davister Merck
    Dan Checketts Jazz Pharmaceuticals
    Dong Xi Gilead 
    Edwin van SteinGSK
    Elena PolverejanJanssen Research & Development 
    Elisa GomezEli Lilly and Company 
    Emilea Norris CDISC
    Fatma ZohraTigermed
    Federica BruneroPPD
    Irfan AliTigermed
    Jennifer, BrittGilead
    John ScottFDA
    Jonathan Siegel Bayer 
    Jozef AertsXML4Pharma
    Junxiang LuoModerna 
    Kevin LiuPfizer 
    Kirti BhattTigermed
    Kim Musgrave Amgen



    Project MembersOrganisation 
    Lauren ShinaberryAbbvie
    Liping SunFDA
    Lisa LinFDA
    Marc Walton Janssen Research & Development 
    Marian MitroiuBiogen
    Matt Baldwin Amgen
    Mindy Mo Bayer
    Munish MehraTigermed
    Naga DontamsettyTakeda 
    Nikhil SudarshanJazz Pharmaceuticals
    Nilani Liyanage Jansen Research & Development 
    Oliver Wirtz Bayer 
    Rama Empati AstraZeneca
    Rama KalyanammaICON
    Rhian Jacob- Moffatt Roche
    Robin WhiteEli Lilly and Company
    Rosanne LaneJanssen Research & Development 
    Samson GhebremariamNovartis 
    Santosh K Lingala Gilead 
    Shahida Tamboli Labcorp 
    Stephen Ruberg Analytix Thinking
    Steve Gilbert Pfizer 
    Steve WilsonFDA
    Sonali AmbureTigermed
    Sudhakar BollineniTigermed 

    Sujitha Susan John

    Novo Nordsik 
    Venkat GajjiTigermed
    Vidya Jayapalan Takeda
    Xiaohan ZouBristol Myers Squibb
    Yongming QuEli Lilly and Company 
    Yun Peng Bristol Myers Squibb
    Zongjun Zhang Eli Lilly and Company